Literature DB >> 26355466

Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study.

Eugénie Penninck1, Mathurin Fumery, Laura Armengol-Debeir, Hélène Sarter, Guillaume Savoye, Dominique Turck, Guillaume Pineton de Chambrun, Francis Vasseur, Jean-Louis Dupas, Eric Lerebours, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet, Corinne Gower-Rousseau.   

Abstract

BACKGROUND: We describe, in a population-based cohort, the incidence of and factors associated with postoperative complications (POCs) in pediatric-onset inflammatory bowel disease.
METHODS: Using the pediatric population-based EPIMAD Cohort (1988-2004), among 692 incident inflammatory bowel disease cases, 128 patients with Crohn's disease (CD) and 25 with ulcerative colitis (UC) (22%) had undergone at least 1 major abdominal surgery at a median age of 16 years [interquartile range, Q1-Q3 = 14-17]. Factors associated with POC were assessed using Cox models.
RESULTS: After a median postoperative follow-up of 8 years (3-12), 76 (49.7%) patients had experienced at least 1 POC with a total of 113 complications. The frequency of severe POC (grade >2) was similar in CD and UC (28% of all complications versus 27%, P = 0.95). A total of 64 early POCs (within 30 d of surgery) were observed in 47 patients (31%), with 33 being infectious and 31 noninfectious, higher in UC than in CD (25% of patients with CD versus 60% of patients with UC, P < 0.001). Forty-nine late POCs (≥30 d) were observed in 37 patients (24%). The occurrence of late POC was similar in UC and CD. The cumulative probability of POC was 31% (95% confidence interval, 24-39) at 1 month, 46% (38-54) at 1 year, and 48% (41-57) at 5 years. Multivariate analysis found that the UC type was the only factor associated with early POC (hazard ratio = 2.9; 95% confidence interval, 1.6-5.4).
CONCLUSIONS: One-half of the children with inflammatory bowel disease had experienced at least 1 POC. Only UC relative to CD was significantly associated with an increased risk of early POC.

Entities:  

Mesh:

Year:  2016        PMID: 26355466     DOI: 10.1097/MIB.0000000000000576

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  5 in total

1.  Risk factors for early postoperative complications and length of hospital stay in ileocecal resection and right hemicolectomy for Crohn's disease: a single-center experience.

Authors:  Christian Galata; Christel Weiss; Julia Hardt; Steffen Seyfried; Stefan Post; Peter Kienle; Karoline Horisberger
Journal:  Int J Colorectal Dis       Date:  2018-05-07       Impact factor: 2.571

2.  Toward a More Sensitive Endpoint for Assessing Postoperative Complications in Patients with Inflammatory Bowel Disease: a Comparison Between Comprehensive Complication Index (CCI) and Clavien-Dindo Classification (CDC).

Authors:  Feng Zhu; Dengyu Feng; Tenghui Zhang; Lili Gu; Weiming Zhu; Zhen Guo; Yi Li; Jianfeng Gong; Ning Li; Jieshou Li
Journal:  J Gastrointest Surg       Date:  2018-05-15       Impact factor: 3.452

Review 3.  Fungal infections in patients with inflammatory bowel disease: A systematic review.

Authors:  George A Stamatiades; Petros Ioannou; George Petrikkos; Constantinos Tsioutis
Journal:  Mycoses       Date:  2018-03-25       Impact factor: 4.377

4.  Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

Authors:  Mathurin Fumery; Philippe Seksik; Claire Auzolle; Nicolas Munoz-Bongrand; Jean-Marc Gornet; Gilles Boschetti; Eddy Cotte; Anthony Buisson; Anne Dubois; Benjamin Pariente; Philippe Zerbib; Najim Chafai; Carmen Stefanescu; Yves Panis; Philippe Marteau; Karine Pautrat; Charles Sabbagh; Jerome Filippi; Marc Chevrier; Pascal Houze; Xavier Jouven; Xavier Treton; Matthieu Allez
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

Review 5.  Inflammatory bowel disease registries for collection of patient iron parameters in Europe.

Authors:  Jonas Halfvarson; Fraser Cummings; Olof Grip; Guillaume Savoye
Journal:  World J Gastroenterol       Date:  2018-03-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.